Anna Wolska

1.5k total citations
61 papers, 913 citations indexed

About

Anna Wolska is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna Wolska has authored 61 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 30 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna Wolska's work include Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers), Lipoproteins and Cardiovascular Health (21 papers) and Lipid metabolism and disorders (16 papers). Anna Wolska is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (27 papers), Lipoproteins and Cardiovascular Health (21 papers) and Lipid metabolism and disorders (16 papers). Anna Wolska collaborates with scholars based in United States, Poland and Canada. Anna Wolska's co-authors include Alan T. Remaley, Alan T. Remaley, Marcelo Amar, Denis Sviridov, Lita A. Freeman, Maureen Sampson, Masako Ueda, Richard L. Dunbar, Diego Lucero and Russell Warnick and has published in prestigious journals such as Circulation, Nature Communications and Circulation Research.

In The Last Decade

Anna Wolska

56 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Wolska United States 16 437 407 278 179 167 61 913
Charles D. Meyers United States 16 375 0.9× 296 0.7× 159 0.6× 109 0.6× 240 1.4× 25 812
Elisenda Climent Spain 16 182 0.4× 434 1.1× 154 0.6× 108 0.6× 132 0.8× 59 790
Yongyan Song China 16 207 0.5× 221 0.5× 167 0.6× 112 0.6× 261 1.6× 58 834
Ana M. Bea Spain 17 217 0.5× 371 0.9× 203 0.7× 110 0.6× 123 0.7× 62 838
Amir F. Ayyobi Canada 11 482 1.1× 342 0.8× 247 0.9× 95 0.5× 170 1.0× 17 789
E Schaefer United States 12 473 1.1× 521 1.3× 251 0.9× 169 0.9× 99 0.6× 13 952
Remco Franssen Netherlands 16 586 1.3× 520 1.3× 493 1.8× 207 1.2× 331 2.0× 26 1.5k
Elisa Campos United States 10 482 1.1× 401 1.0× 232 0.8× 219 1.2× 88 0.5× 16 778
Xin Su China 17 208 0.5× 139 0.3× 163 0.6× 85 0.5× 227 1.4× 48 852
L.D. Dikkeschei Netherlands 15 306 0.7× 262 0.6× 151 0.5× 53 0.3× 149 0.9× 41 873

Countries citing papers authored by Anna Wolska

Since Specialization
Citations

This map shows the geographic impact of Anna Wolska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wolska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wolska more than expected).

Fields of papers citing papers by Anna Wolska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wolska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wolska. The network helps show where Anna Wolska may publish in the future.

Co-authorship network of co-authors of Anna Wolska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wolska. A scholar is included among the top collaborators of Anna Wolska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wolska. Anna Wolska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sampson, Maureen, Anna Wolska, Jeffrey W. Meeusen, et al.. (2025). Lipid Ratio Plot: A Simple Graphical Approach for Investigating the Accuracy of LDL Cholesterol Equations or Direct Assays. The Journal of Applied Laboratory Medicine. 10(5). 1154–1167.
2.
Sampson, Maureen, et al.. (2025). Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank. Arteriosclerosis Thrombosis and Vascular Biology. 45(10). e512–e522. 3 indexed citations
3.
Wolska, Anna, Bianca Weinstock‐Guttman, Niels Bergsland, et al.. (2025). Frailty Exacerbates Disability in Progressive Multiple Sclerosis. Annals of Clinical and Translational Neurology.
4.
Sampson, Maureen, Anna Wolska, Jeffrey W. Meeusen, et al.. (2025). A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol. Clinical Chemistry. 71(11). 1125–1137. 2 indexed citations
5.
Shalaurova, Irina, Anna Wolska, Richard W. Browne, et al.. (2025). Endogenous Ketone Bodies Are Associated with Metabolic Vulnerability and Disability in Multiple Sclerosis. Nutrients. 17(4). 640–640. 2 indexed citations
6.
Shalaurova, Irina, Richard W. Browne, Anna Wolska, et al.. (2024). Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis. Nutrients. 16(17). 2866–2866. 1 indexed citations
7.
Shearer, Joseph J., Jungnam Joo, Maureen Sampson, et al.. (2024). Frailty and Metabolic Vulnerability in Heart Failure: A Community Cohort Study. Journal of the American Heart Association. 13(8). e031616–e031616. 4 indexed citations
8.
Joo, Jungnam, Joseph J. Shearer, Anna Wolska, et al.. (2024). Incremental Value of a Metabolic Risk Score for Heart Failure Mortality: A Population-Based Study. Circulation Genomic and Precision Medicine. 17(2). e004312–e004312. 1 indexed citations
9.
Garcia, Erwin, Irina Shalaurova, Steven P. Matyus, et al.. (2024). A High-Throughput NMR Method for Lipoprotein-X Quantification. Molecules. 29(3). 564–564. 2 indexed citations
10.
Nehzat, Nasim, Anna Wolska, Irina Shalaurova, et al.. (2024). Dyslipidemias in multiple sclerosis. Multiple Sclerosis and Related Disorders. 91. 105841–105841. 2 indexed citations
11.
Subramanian, Poorani, Shreni Mistry, Anna Wolska, et al.. (2023). Colchicine effects on the gut microbiome in adults with metabolic syndrome. Bioscience of Microbiota Food and Health. 42(4). 236–242. 3 indexed citations
12.
Wolska, Anna, et al.. (2023). Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management. The Journal of Clinical Endocrinology & Metabolism. 108(9). 2424–2434. 7 indexed citations
13.
Wolska, Anna, et al.. (2023). Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?. Journal of Clinical Medicine. 12(17). 5737–5737. 14 indexed citations
14.
Sviridov, Denis, Milton Pryor, Steven K. Drake, et al.. (2023). Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice. Frontiers in Cardiovascular Medicine. 10. 1223920–1223920. 3 indexed citations
15.
Levine, J, Tushar Patel, Sheila M. Brady, et al.. (2022). Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome. Obesity. 30(2). 358–368. 10 indexed citations
16.
Sampson, Maureen, Anna Wolska, James D. Otvos, et al.. (2022). Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations. Biomedicines. 10(12). 3156–3156. 15 indexed citations
17.
Sampson, Maureen, Rami A. Ballout, Daniel Soffer, et al.. (2021). A new phenotypic classification system for dyslipidemias based on the standard lipid panel. Lipids in Health and Disease. 20(1). 170–170. 11 indexed citations
18.
Lightbourne, Marissa, Anna Wolska, Brent S. Abel, et al.. (2020). Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin. Journal of the Endocrine Society. 5(2). bvaa191–bvaa191. 6 indexed citations
19.
Demidowich, Andrew P., Anna Wolska, J Levine, et al.. (2019). Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial. Journal of clinical lipidology. 13(6). 1016–1022.e2. 11 indexed citations
20.
Wolska, Anna, et al.. (1964). CATTLE LEUKOSES AND HUMAN LYMPHADENOSES. A PRELIMINARY REPORT.. PubMed. 22. 3–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles D. Meyers Breakdown of academic impact, for papers by Elisenda Climent Breakdown of academic impact, for papers by Yongyan Song Breakdown of academic impact, for papers by Ana M. Bea Breakdown of academic impact, for papers by Amir F. Ayyobi Breakdown of academic impact, for papers by E Schaefer Breakdown of academic impact, for papers by Remco Franssen Breakdown of academic impact, for papers by Elisa Campos Breakdown of academic impact, for papers by Xin Su Breakdown of academic impact, for papers by L.D. Dikkeschei
Rankless by CCL
2026